| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |